Gan & Lee Pharmaceuticals Hits Day High with 7.07% Surge in Stock Price

Gan & Lee Pharmaceuticals Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.07% on June 29, 2026. The stock reached an intraday high of CNY 57.99, showcasing its strong market activity. This performance stands in contrast to the China Shanghai Composite, which only saw a 1.16% increase on the same day. Over the past month, Gan & Lee has demonstrated a robust growth trajectory with a 10.12% increase, while the broader market has remained relatively flat, posting a mere 0.13% gain. The company has also shown resilience over the past year, generating a return of 37.52%, significantly outperforming the China Shanghai Composite's 18.97% return. Financially, Gan & Lee reported net sales of CNY 2,062.17 million, reflecting a 23% growth. The company has maintained positive results for the last eight consecutive quarters, with a return on capital employed (ROCE) reaching 8.23%. Despite some long-term growth concerns, the stock's current performance highlights its competitive position within the pharmaceuticals and biotechnology sector.